Cannasouth Limited

Healthcare

A biopharmaceutical R&D company, Cannasouth Limited (NZX:CBD) is established in the Waikato heartland of New Zealand. Cannasouth is engaged in the commercial development of the medicinal cannabis compounds such as Cannabidiol, Tetrahydrocannabinol (THC) and other associated chemical constituents that are present in the cannabis plant. The Company is working with the aim of developing next-generation cannabinoid medicines to provide support to the health outcomes of patients and to enhance the quality of life.

Similar Companies

Load More
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK